CCL20 and melanoma: The ability of CCR6-expressing pDCs to migrate in response to CCL20 was demonstrated in transwell migration assays, suggesting that CCL20 produced in the TME might participate in recruiting CCR6-expressing pDCs in melanoma tumors [38].